Lidocaine Articles
US FDA approves Actavis generic copy of GSK’s Valtrex and Hi-Tech’s lidocaine; Cephalon wins Fentora patent case
25 March 2011
Anesiva shareholders agree to Arcion takeover
8 December 2009
Sciele and Plethora present PSD502 PE data
30 April 2009
Plethora's spray delays orgasm by six times longer
8 April 2009
Teikoku to help Eisai develop donepezil skin patch
16 March 2009
Opana growth drives Endo's profit up 15%
16 March 2009
FDA warns over use of topical anesthetics
26 January 2009
Plethora stock jumps 55% on study results
17 November 2008
Anika signs up Elevess disribution in Mexico, Chile, Peru, S Korea
10 November 2008
Anesiva cuts workforce by 20%
15 September 2008
Versatis recommended for PHN in Scotland
1 September 2008
Urigen granted key US patent for PBS drug
1 September 2008
Vyteris to pursue joint developments in pain mangement
11 August 2008
FDA accepts Anesiva's Zingo sNDA
26 May 2008
Anesiva expands Zingo deal with Sigma-Tau
5 May 2008
EUSA's Rapydan OKed in 12 EU markets
17 March 2008
Galderma and ZARS extend Pliaglis deal
17 March 2008
Alta Partners invests $25M in Anesiva
24 December 2007
Plethora's premature ejaculation inhaler enters Ph III
24 December 2007
EUSA Pharma enters $30M financing round
17 December 2007
Less IV procedure pain with Anesiva's Zingo
5 November 2007
EUSA's Rapydan completes European MRP
29 October 2007
Anesiva and Sagent in deal to co-promote Zingo to US hospitals
22 October 2007
Anesiva's Zingo cleared by FDA
3 September 2007
Auriga Labs launches Xyralid in USA
16 July 2007
Anika's Elevess gets EU CE Mark
23 April 2007
AstraZeneca to sell French plant
12 February 2007
Grunenthal's Versatis approved by UK MHRA
15 January 2007
Adolor drops sterile lidocaine patch development
6 November 2006
Abraxis completes purchase of AstraZeneca brands
3 July 2006
Plethora's PSD502 Ph II enrollment complete
19 September 2005
US orphan status for TheraQuest's TQ-1017
22 August 2005
Columbia Labs raises $6.9M in stock offering
16 May 2005
Positive data for Endo's Lidoderm patch in OA
11 April 2005
US Pharmacy launches own-brand preparation
14 February 2005
Endo Pharma sees 2nd-qtr profits slump
26 July 2004
Corus Pharma raises $60 million
19 April 2004
Endo net sales surge 49% in 2003
23 February 2004
Endo Pharma converting to own sales reps
22 September 2003
SkyePharma licenses key drugs to Endo
13 January 2003
EMLA cream only for hospital use in USA
13 January 2003
Endo sales to reach $440M in fiscal 2003
6 January 2003
Guilford posts $16.8M loss in 2nd quarter
19 August 2002
Vyteris files for pain patch approval in USA
10 June 2002
PowderJect sells drugs business to AlgoRx
25 March 2002
Guilford sees Gliadel unit sales up 42%
25 February 2002
Kaken, Teikoku to jointly develop shingles patch
13 December 2001
AstraZeneca cashes in on sale of dental unit
22 January 2001
Vaccines acquisition set to drive near-term growth at PowderJect
12 December 2000
Pan-European biotech - a guide to the landscape by Lehman Bros
6 November 2000
PowderJect has strong fundamentals, says broker
10 December 1999
Positive 1st-qtr news from AstraZeneca
26 May 1999
Bioject - one step ahead in a needle-free world
10 February 1999
ICAgen To Start Trials Of Three Drugs In 1999
25 November 1998
Chiroscience Stock Yo-Yos After Gene Discovery
7 October 1998
Nortran Tests Local Anesthetic In Phase II
23 July 1998
Sound Platform Set Up At PowderJect
15 June 1998
Net Loss Plunges To $270 Million At Fujisawa
21 May 1998
Chiroscience, Powderject To Start US Trials Of Needleless Anesthetic
12 February 1998
Highlights Of Astra's Pipeline Presentation
30 January 1998
Cordarone Gives Early Benefit In Out-Of-Hospital Setting
20 November 1997
Fujisawa Sees 31% Net Income Rise For FY1996
26 May 1997
New AMI Guidelines Update Drug Recommendations
18 November 1996
Russia Gets Hooked On Imported Drugs
14 October 1996
Upbeat Alza Unveils Revamped Pipeline
19 February 1996
FDA Year-End Approvals Round-Up
8 January 1996
Medeva "Not For Sale" But Is On Track For Growth
24 July 1995
Fujisawa Net Down Though Operating Income Soars
29 May 1995
Outstanding 1st Qtr Performance For Astra
22 May 1995
Astra Collaboration For Analgesia R&D
10 April 1995
Astra Pretax Profit Rockets 23%, Fuelled By Losec
27 February 1995
Copley Receives Approval
13 February 1995
Astra Updates On Its R&D Pipeline
5 December 1994
FDA Panel Backs IV Cordarone Approval
31 October 1994
EXPANDING PHARMA MARKET IN TURKEY
10 January 1994
NEW US OTC REGS WARN AGAINST MIXING DRUGS
6 September 1993
FAST APPROVAL FOR STERLING WINTHROP
22 March 1993
FUJISAWA HIT BY JAPAN DRUG PRICING MOVES
1 June 1992
Showing 1-88 of 88 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
